Kabra Drugs Board of Directors
Get the latest insights into the leadership at Kabra Drugs. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| N Aravind | Managing Director |
| Kuniamuthur Nanjappan Anand | Executive Director |
| Nikita Sinha | Non Executive Independent Director |
| A Anitha | Non Executive Independent Director |
| Monika Sanwal | Company Secretary & Compliance Officer |
| Ritu Tiwari | Non Executive Independent Director |
Kabra Drugs FAQs
The board at Kabra Drugs consists of experienced professionals, including N Aravind, Kuniamuthur Nanjappan Anand, and others, overseeing the company’s strategic and corporate governance.
Directors at Kabra Drugs are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, N Aravind is the current chairman at Kabra Drugs.
Executive directors at Kabra Drugs are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Kabra Drugs adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Kabra Drugs, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
